Closing Bell: Trump’s fresh tariff shock knocks ASX lower; gold cushions losses

Fresh tariff drama out of the US rattled markets on Monday, sending the ASX lower as investors rotated into gold and out of AI-linked tech names.

Resources Top 5: Lodestar’s heavy rare earth hits drive strong gains

Heavy rare earth hits in Arizona, a $220m gold funding deal and a bullish broker note kept small-cap resources traders busy on Monday.

Kristie Batten: TG Metals on the pathway to gold production

As drilling extends strike and depth at Van Uden, TG Metals is positioning the WA gold project for a bigger resource and a potential pathway to production.

Lumos achieves first enrolment milestone in paediatric study for point-of-care respiratory test

Lumos reaches enrolment milestone in a paediatric clinical study assessing use of its FebriDx point of care test, to differentiate bacterial from non-bacterial acute respiratory infections.

Neurotech’s NTI164 shows strong long-term safety in 90-day canine toxicology study

Neurotech International has announced positive results from a 90-day repeat-dose oral toxicity canine study of its lead drug candidate NTI164.

ASX growth companies showcase momentum at JMM Perth Investor Lunch